Status:
Enrolling
Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
Phase
IV
Age
18-55
Sponsor
Marta Peciña, MD PhD
Enrollment code
120
Last Updated
Jun 6, 2025
Locations
1 Country
Inclusion criteria:
• Adults, age 18-55 years; fluent in English and with the capacity to understand the nature of the study and sign the written informed consent since the research instruments used in this study are not available in other languages;
Exclusion criteria:
• Pregnant or breastfeeding or plan to become pregnant over the duration of the study;